Phase II Trial of Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Resectable or Borderline Resectable Pancreatic Adenocarcinoma
The purpose of this phase II study is to evaluate the efficacy of Stereotactic Body Radiation Therapy (SBRT) compared to conventional concurrent chemotherapy and radiation therapy.
Study ID: PRO33061
Trial Phase: Phase II
Trial Sponsor: Medical College of Wisconsin
Therapies Used in This Trial: Radiation Therapy, Stereotactic body radiotherapy (SBRT)